01884nam a2200385 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020002200112020002200134020002500156020001800181020002700199040002100226035002100247050002500268082001500293245020400308260004800512300002400560504005100584505034500635533015200980650002701132650005601159650002201215655002901237700002601266700004001292700002301332710001701355856012601372ebr10479992CaPaEBRm        u        cr cn|||||||||070307s2006    enkad   sb    001 0 eng d  z  2007295856  z0745324037 (hbk.)  z0745324029 (pbk.)  z9780745324029 (pbk.)  z9780745324036  z9781849642712 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)65626362014aRA401.A1bP69 2006eb04a615/.122204aThe power of pillsh[electronic resource] :bsocial, ethical and legal issues in drug development, marketing, and pricing /cedited by Jillian Clare Cohen, Patricia Illingworth, and Udo Sch�uklenk.  aLondon ;aAnn Arbor, Mich. :bPluto,c2006.  axiv, 297 p. :bill.  aIncludes bibliographical references and index.0 apt. 1. Pharmaceutical industry, profits and obligations -- pt. 2. Justice : medicines as global public goods -- pt. 3. The social, ethical, and political challenge : neglected diseases -- pt. 4. Patents and access to medicines -- pt. 5. Research ethics -- pt. 6. Political activism and treatment access -- pt . 7. National responsibilities.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aPharmaceutical policy. 0aPharmaceutical industryxMoral and ethical aspects. 0aDrug development. 7aElectronic books.2local1 aCohen, Jillian Clare.1 aIllingworth, Patricia M. L.,d1954-1 aSch�uklenk, Udo.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10479992zAn electronic book accessible through the World Wide Web; click to view